Glutathione conjugates with heavy metals and toxins helping the body to eliminate these harmful substances
Fund Details Issuer Roundhill Investments Fund Name Roundhill GLP-1 & Weight Loss ETF Tax Classification Regulated Investment Company Stock Exchange NASDAQ Current Symbol NASDAQ:OZEM Inception Date 5/20/2024 Fund Manager Will Hershey, Tim Maloney, Dave Mazza, Drew Walsh Previous Symbol NASDAQ:OZEM Web N/A Phone N/A Fund Focus Asset Class Equity Benchmark N/A Category Strategy Focus Theme Development Level Blended Development Region Global Number of Holdings 53 Fund Statistics Assets Under Management $0.00 Average Daily Volume $0.00 Discount/Premium 0.00% Administrator, Advisor and Custodian Administrator U.S
Precautions If you have an electrolytes imbalance, asthma, liver or kidney disease, or low blood pressure, please consult your physician before taking this medicine
Furthermore, the amylin receptor agonist, developed by Shionogi and Verdiva Bio, has garnered attention for its oral and subcutaneous formulations, and the two companies have formed a collaboration to develop and promote it worldwide